ArticleCurrent oncology (Toronto, Ont.)2024

A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline-Taxane Chemotherapy in Early HER-2 Negative Breast Cancer.

Danilo Giffoni de Mello Morais Mata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.